Jefferson outlasted the FTC to absorb Einstein, growing from 14 to 18 hospitals

Jefferson Health and Einstein Healthcare Network, two Philadelphia providers, announced their merger in March 2018. The FTC challenged it — the agency's first big hospital-merger block attempt after a three-year lull, since it had last acted in 2017 to block Sanford Health's acquisition of Mid Dakota Clinic. The agency alleged the two competed directly and that together they would control at least 60% of inpatient services around north Philadelphia and 70% of inpatient rehabilitation services.

The challenge collapsed in court. In December 2020, Judge Gerald Pappert of the Eastern District of Pennsylvania declined to issue an injunction, saying he was not convinced the merger would raise prices for insurers, that there were 'abundant healthcare options' in the Philadelphia region, and that the insurer market was far more consolidated than the provider sector. The Third Circuit then denied the FTC's bid to bar the deal pending appeal.

On March 1, 2021, Jefferson announced the FTC would no longer challenge the merger: commissioners voted 4-0 to voluntarily dismiss the appeal, and the FTC's case summary was updated accordingly. Jefferson said it would move forward as there were 'no further barriers', with closing expected within six months. With Einstein under its umbrella, Jefferson expands from 14 to 18 hospitals and says the deal will reinvigorate health education and research opportunities.

Deal cleared to close; Jefferson to expand from 14 to 18 hospitals, adding Einstein's network and reinvigorating health education and research.

It was the test case for whether the FTC could still stop hospital consolidation — and the agency lost at every level.

The judge's market-definition reasoning (abundant options; insurers more consolidated than providers) became a template argument for merging systems.

Jefferson's three-year persistence through litigation shows what closing a contested deal actually costs and takes.

The 4-0 voluntary dismissal is a rare, documented regulator retreat, useful as a reference point for any antitrust-heavy deal.

The expansion number (14 to 18 hospitals) is a clean before/after for merger-driven scale.

Antitrust fights are won on market definition: a judge who sees 'abundant healthcare options' and a consolidated insurer side will let a deal close — keep it alive through the courts.

The deal was expected to close within six months of the FTC's March 2021 withdrawal, with Jefferson describing 'no further barriers'. The agency's setback foreshadowed a rough patch for hospital-merger challenges; Jefferson kept consolidating in the region afterward.